Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 67

1.
2.

Metabolomics of autism spectrum disorders: early insights regarding mammalian-microbial cometabolites.

Mussap M, Noto A, Fanos V.

Expert Rev Mol Diagn. 2016 Aug;16(8):869-81. doi: 10.1080/14737159.2016.1202765. Epub 2016 Jun 30. Review.

PMID:
27310602
3.

The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder.

Li Q, Zhou JM.

Neuroscience. 2016 Jun 2;324:131-9. doi: 10.1016/j.neuroscience.2016.03.013. Epub 2016 Mar 8. Review.

PMID:
26964681
4.

Gut microbiota in autism and mood disorders.

Mangiola F, Ianiro G, Franceschi F, Fagiuoli S, Gasbarrini G, Gasbarrini A.

World J Gastroenterol. 2016 Jan 7;22(1):361-8. doi: 10.3748/wjg.v22.i1.361. Review.

5.

Mathematical modeling of the methionine cycle and transsulfuration pathway in individuals with autism spectrum disorder.

Vargason T, Howsmon DP, Melnyk S, James SJ, Hahn J.

J Theor Biol. 2017 Mar 7;416:28-37. doi: 10.1016/j.jtbi.2016.12.021. Epub 2016 Dec 29.

6.

Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders.

Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X.

Int J Dev Neurosci. 2015 Nov;46:27-32. doi: 10.1016/j.ijdevneu.2015.06.006. Epub 2015 Jul 3.

PMID:
26150135
7.

Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.

Diémé B, Mavel S, Blasco H, Tripi G, Bonnet-Brilhault F, Malvy J, Bocca C, Andres CR, Nadal-Desbarats L, Emond P.

J Proteome Res. 2015 Dec 4;14(12):5273-82. doi: 10.1021/acs.jproteome.5b00699. Epub 2015 Nov 23.

PMID:
26538324
8.

Microbiome Disturbances and Autism Spectrum Disorders.

Rosenfeld CS.

Drug Metab Dispos. 2015 Oct;43(10):1557-71. doi: 10.1124/dmd.115.063826. Epub 2015 Apr 7. Review.

9.

An agent-based modeling framework for evaluating hypotheses on risks for developing autism: effects of the gut microbial environment.

Weston B, Fogal B, Cook D, Dhurjati P.

Med Hypotheses. 2015 Apr;84(4):395-401. doi: 10.1016/j.mehy.2015.01.027. Epub 2015 Jan 28.

PMID:
25670416
10.

A preliminary investigation on the relationship between gut microbiota and gene expressions in peripheral mononuclear cells of infants with autism spectrum disorders.

Inoue R, Sakaue Y, Sawai C, Sawai T, Ozeki M, Romero-Pérez GA, Tsukahara T.

Biosci Biotechnol Biochem. 2016 Dec;80(12):2450-2458. Epub 2016 Sep 1.

PMID:
27581276
11.

The genetics of autism.

Muhle R, Trentacoste SV, Rapin I.

Pediatrics. 2004 May;113(5):e472-86. Review.

PMID:
15121991
12.

Application of a hierarchical enzyme classification method reveals the role of gut microbiome in human metabolism.

Mohammed A, Guda C.

BMC Genomics. 2015;16 Suppl 7:S16. doi: 10.1186/1471-2164-16-S7-S16. Epub 2015 Jun 11.

14.

Hypothesis for a systems connectivity model of Autism Spectrum Disorder pathogenesis: links to gut bacteria, oxidative stress, and intestinal permeability.

Heberling CA, Dhurjati PS, Sasser M.

Med Hypotheses. 2013 Mar;80(3):264-70. doi: 10.1016/j.mehy.2012.11.044. Epub 2012 Dec 27.

PMID:
23273906
15.

The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder.

Ko C, Kim N, Kim E, Song DH, Cheon KA.

Behav Brain Funct. 2016 Jun 27;12(1):20. doi: 10.1186/s12993-016-0105-0.

16.

Prevalence and Characteristics of Autism Spectrum Disorder Among Children Aged 8 Years--Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2012.

Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, Daniels J, Durkin MS, Fitzgerald RT, Kurzius-Spencer M, Lee LC, Pettygrove S, Robinson C, Schulz E, Wells C, Wingate MS, Zahorodny W, Yeargin-Allsopp M; Centers for Disease Control and Prevention (CDC).

MMWR Surveill Summ. 2016 Apr 1;65(3):1-23. doi: 10.15585/mmwr.ss6503a1. Erratum in: MMWR Morb Mortal Wkly Rep. 2016;65(15):404.

PMID:
27031587
17.

Comparative analysis of targeted metabolomics: dominance-based rough set approach versus orthogonal partial least square-discriminant analysis.

Blasco H, Błaszczyński J, Billaut JC, Nadal-Desbarats L, Pradat PF, Devos D, Moreau C, Andres CR, Emond P, Corcia P, Słowiński R.

J Biomed Inform. 2015 Feb;53:291-9. doi: 10.1016/j.jbi.2014.12.001. Epub 2014 Dec 11.

18.

Potential serum biomarkers from a metabolomics study of autism.

Wang H, Liang S, Wang M, Gao J, Sun C, Wang J, Xia W, Wu S, Sumner SJ, Zhang F, Sun C, Wu L.

J Psychiatry Neurosci. 2016 Jan;41(1):27-37.

19.

Urinary 3-(3-Hydroxyphenyl)-3-hydroxypropionic Acid, 3-Hydroxyphenylacetic Acid, and 3-Hydroxyhippuric Acid Are Elevated in Children with Autism Spectrum Disorders.

Xiong X, Liu D, Wang Y, Zeng T, Peng Y.

Biomed Res Int. 2016;2016:9485412. doi: 10.1155/2016/9485412. Epub 2016 Mar 30.

20.

GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders.

El-Ansary A, Al-Ayadhi L.

J Neuroinflammation. 2014 Nov 19;11:189. doi: 10.1186/s12974-014-0189-0.

Supplemental Content

Support Center